In the BioHarmony Drug Report Database

"Preview" Icon

Clonazepam

Klonopin, Klonopin Rapidly Disintegrating (clonazepam) is a small molecule pharmaceutical. Clonazepam was first approved as Klonopin on 1982-01-01. It is used to treat absence epilepsy, bipolar disorder, dysarthria, lennox gastaut syndrome, and myoclonic epilepsies amongst others in the USA. The pharmaceutical is active against gamma-aminobutyric acid receptor subunit alpha-1, gamma-aminobutyric acid receptor subunit alpha-2, and gamma-aminobutyric acid receptor subunit alpha-3.

 

Trade Name

 

Klonopin, Klonopin Rapidly Disintegrating
 

Common Name

 

clonazepam
 

ChEMBL ID

 

CHEMBL452
 

Indication

 

absence epilepsy, bipolar disorder, dysarthria, lennox gastaut syndrome, myoclonic epilepsies, neuralgia, panic disorder, restless legs syndrome, schizophrenia, seizures, tic disorders
 

Drug Class

 

Antianxiety agents (diazepam type)

Image (chem structure or protein)

Clonazepam structure rendering